Achilles Therapeutics Stock (NASDAQ: ACHL)

Achilles Therapeutics Stock (NASDAQ:ACHL), Trade Ideas

Achilles Therapeutics

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Earnings

News

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

Markets

Trading Ideas

ACHL

ALUR

CADL

EFTR

TCBP

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday.

The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&amp;P 500 also fell, dropping, 0.28% to 5,197.03.

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results

Small Cap

Movers

ABIO

ADXN

AQST

AXTI

CASA

DXYZ

EIGR

ENPH

FAAS

FLGC

GCTS

GRRR

HUBS

Kintara Therapeutics, Inc. - Common Stock

KTRA

KYCH

LEVI

LGVC

MGNX

MSTR

Nuveen California Dividend Advantage Municipal Fund 2

ONMD

PARA

RELI

RENT

SLNA

SMXT

SPWH

STAA

TVGN

VIEW

VSTE

XTIA

ZETA

Shares of  STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance.

STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday.

The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&amp;P 500 also rose, gaining, 0.75% to 5,250.72.

Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings

Achilles Therapeutics plc - American Depositary Shares

Achilles Therapeutics PLC

<p>Keybanc  analyst Steve Barger   maintains Westinghouse Air Brake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) with a Overweight and raises the price target from $155 to $185.</p>


Price Target

Analyst Ratings

Keybanc Maintains Overweight on Westinghouse Air Brake, Raises Price Target to $185

FDA Says Cardinal Health Failure To Ensure Syringes In Convenience Kits, U.S. Importing & Distributing Have 510(k) Clearance Prevented FDA From Checking Risks

WIIM

First American Financial shares are trading lower after the company missed Q1 EPS and sales estimates.

DOOR

Masonite Holders Approve Transaction With Owens Corning

<p>Keybanc  analyst Jason Ader   maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Overweight and lowers the price target from $1000 to $950.</p>


Keybanc Maintains Overweight on ServiceNow, Lowers Price Target to $950

<p>Deutsche Bank  analyst Mark Devries   maintains Mr. Cooper Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) with a Buy and raises the price target from $88 to $90.</p>


COOP

Deutsche Bank Maintains Buy on Mr. Cooper Gr, Raises Price Target to $90

<p>Deutsche Bank  analyst Zurn Elkay   maintains Zurn Elkay Water (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZWS#NYSE">ZWS</a>) with a Buy and lowers the price target from $37 to $36.</p>


Deutsche Bank Maintains Buy on Zurn Elkay Water, Lowers Price Target to $36

Dividends

Brazil Government Proposes In Shareholders Meeting That Petrobras Pays Out 50% Of Extra Dividends Relative To 2023 Results

<p><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.averydennison.com&amp;esheet=53948812&amp;newsitemid=20240425830275&amp;lan=en-US&amp;anchor=Avery+Dennison+Corporation&amp;index=1&amp;md5=6e4a2194b1427c47e6a6d3cf92826478">Avery Dennison Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) today announced that its Board of Directors has increased the company's quarterly dividend. The board declared a quarterly dividend of $0.88 per share, representing an increase of approximately 9% over the previous dividend rate. The dividend for the second quarter is payable on June 20, 2024 to shareholders of record as of June 5, 2024.</p>


Avery Dennison Increases Quarterly Dividend From $0.81 To $0.88 Per Share

<p>Deutsche Bank  analyst Emmanuel Rosner   maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Hold and raises the price target from $123 to $136.</p>


TSLA

Deutsche Bank Maintains Hold on Tesla, Raises Price Target to $136

<p>Real estate has long been a cornerstone of wealth generation, and as 19th-century British philosopher and economist John Stuart Mill once said, &#8220;Landlords grow rich in their sleep.&#8221; However, being a landlord isn&#8217;t always as passive as it seems. From screening tenants and preparing lease agreements to handling maintenance and chasing rent payments, managing a rental property can be a time-consuming and stressful endeavor.</p>
<p>Fortunately, there are ways to earn monthly rental income without the hassles of being a landlord. One popular option is investing in real estate investment trusts (REITs), which are essentially giant landlords that own income-producing real estate and collect rent from tenants. REITs are required by law to distribute at least 90% of their taxable income to shareholders as dividends, making them an attractive choice for investors seeking passive income.</p>
<h2 class="wp-block-heading">Don&#8217;t Miss:</h2>
<ul>
<li>Passive income investments are one of the most trusted methods for riding out a recession, so it's no surprise that people are turning to these <a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail">high-yield real estate notes that pay a fixed 7.5% &#8211; 9%.</a></li>
<li>Elon Musk has reportedly bought 6,000 acres of land just outside of Austin.<a href="https://www.benzinga.com/real-estate/23/05/32537165/elon-musk-is-bullish-on-austin-heres-how-to-invest-in-the-citys-growth-before-he-floods-it-with-new"> Here&#8217;s how to invest in the city&#8217;s growth</a> before he floods it with new tech workers.</li>
</ul>
<p><strong>Realty Income Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>), known as &#8220;The Monthly Dividend Company,&#8221; is a prime example of a REIT that pays its shareholders on a monthly basis. With a 55-year operating history, Realty Income has declared 646 consecutive monthly dividends and has increased its payout for the last 25 consecutive years. The company currently offers a 5.75% dividend yield, with a monthly dividend of $0.257 per share.</p>
<p>To earn $1,000 per month from Realty Income, an investor would need to own approximately 3,891 shares, which at the current share price of $53.66, would require an investment of around $208,791. For a more modest goal of $200 per month, an investor would need roughly 778 shares, or $41,747 worth of Realty Income stock.</p>
<p>While REITs like Realty Income provide an accessible way to invest in real estate without the responsibilities of property management, they come with their own set of risks. REIT shares can be volatile, and dividends are not guaranteed. Despite its impressive track record, Realty Income shares have fallen about 13% in the past year, though some analysts see a potential rebound on the horizon.</p>
<p>Another option for investors looking to take a more hands-on approach to real estate investing without the full responsibilities of being a landlord is <a href="https://www.benzinga.com/go/arrived-yf"><strong>Arrived Homes</strong></a>. This platform, backed by Amazon founder Jeff Bezos, allows individuals to invest in shares of specific rental properties for as little as $100.</p>
<p>Arrived gives investors more control than traditional REITs by enabling them to choose the specific properties they want to invest in. Investors can browse through <a href="https://www.benzinga.com/go/arrived-yf">available properties</a> on the platform, review details about each property&#8217;s location, tenant and expected returns, and then decide which properties best fit their investment goals.</p>
<p>Arrived handles all the property management responsibilities, including finding tenants, collecting rent and handling maintenance, while investors sit back and collect their share of the rental income and any appreciation in the property&#8217;s value. With a monthly payout and price appreciation, Arrived offers a compelling alternative for investors looking to diversify their real estate holdings and have more control over their investments.</p>
<p>The bottom line? While becoming a landlord can be a lucrative way to generate passive income, it&#8217;s not the only option. REITs like Realty Income and platforms like Arrived Homes offer investors the opportunity to earn monthly rental income without the hassles of property management. As with any investment, it&#8217;s essential to conduct thorough research and understand the risks involved before committing your hard-earned money.</p>
<p><a href="https://www.benzinga.com/go/arrived-yf"><strong>View available properties on Arrived</strong></a></p>
<h2 class="wp-block-heading"><strong>Read Next:</strong></h2>
<ul>
<li>Investing in real estate just got a whole lot simpler. This<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> Jeff Bezos-backed startup</a> will allow you to become a landlord in just 10 minutes, and you only need $100.</li>
<li>Miami is expected to take New York's place as the U.S. Financial Capital. <a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital">Here's how you can invest in the city with as little as $500</a> before that happens.</li>
</ul>


REIT

Real Estate

How To Earn $1,000 In Monthly Rental Income While You Sleep (Without The Landlord Duties)

<p>Keybanc  analyst Justin Patterson   maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and lowers the price target from $555 to $475.</p>


Keybanc Maintains Overweight on Meta Platforms, Lowers Price Target to $475

<p><strong>Mullen Automotive, Inc.</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares are&nbsp;<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading lower on Thursday.</a></p>
<p>In a press release, the company said&nbsp;it&nbsp;received certification from the&nbsp;California Air Resources Board on the 2025 Mullen THREE,<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38431172/mullen-announces-new-carb-approval-for-2025-class-3-ev-cab-chassis-truck" rel="noreferrer noopener">&nbsp;Class 3 all-electric low cab forward chassis truck.</a></p>
<p>&#8220;Our vehicles are CARB approved and ready for delivery with many states and local governments offering&nbsp;very strong&nbsp;incentives to electrify commercial fleets,&#8221; said David Michery, CEO and chairman of Mullen Automotive.</p>
<p>Mullen Automotive said that the certification&nbsp;is awarded&nbsp;to vehicle manufacturers who meet specific emissions standards in compliance with CARB regulations.</p>
<p>CARB-compliant states and locations include California, Connecticut, Colorado, Delaware, Maine, Maryland, Massachusetts, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, Vermont&nbsp;and&nbsp;the District of Columbia.</p>
<p>CARB certification opens the Mullen THREE to critical state EV incentive programs, which vary by each eligible CARB-compliant state.&nbsp;</p>
<p>The certification&nbsp;takes on even more significance&nbsp;with CARB&#8217;s recent&nbsp;Advanced Clean Fleets regulation.</p>
<p>Earlier this week, the company announced the first phase completion of battery line integration at its&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38356943/mullens-new-high-energy-facility-marks-phase-one-completion-of-battery-pack-assembly-line" rel="noreferrer noopener">high-energy facility on Monday</a>.</p>
<p>Mullen said the phase one project culminated in the successful startup, debugging, and early-stage commissioning of the initial two battery assembly lines.&nbsp;</p>
<p>Production line start&nbsp;is currently targeted&nbsp;for early 2025&nbsp;and&nbsp;at volume production, Mullen expects to hire over 200 people for&nbsp;both&nbsp;battery&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38409904/whats-going-on-with-ev-maker-mullen-automotives-stock" rel="noreferrer noopener">production and operational support.</a></p>
<p><strong>Price Action</strong>: MULN shares are trading lower by 15.1%to $3.20 at last check Thursday.</p>
<p><em>Image: Courtesy of Mullen Automotive, Inc. </em></p>


Equities

General

MULN

Mullen Automotive Stock Falls Over 15% - What's Going On?

European Aeronautic Defence And Space Unsponsored

EADSY

Airbus CEO Says We Would Not Want Important Work Packages To Be Procured From Our Main And Almost Sole Competitor; Cannot Predict Timeline In Spirit Talks

<p>In the last three months, 4 analysts have published ratings on Interpublic Gr of Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.0, a high estimate of $37.00, and a low estimate of $31.00. No alteration is observed as the current average remains at the previous average price target. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714064502_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Interpublic Gr of Cos. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Cahall</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$31.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>David Karnovsky</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Steven Cahall</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$32.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Julien Roch</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Interpublic Gr of Cos. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Interpublic Gr of Cos compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Interpublic Gr of Cos's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Interpublic Gr of Cos's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/IPG/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Interpublic Gr of Cos analyst ratings.</strong></a></p>
<h2>All You Need to Know About Interpublic Gr of Cos</h2>
<p>Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe.</p>
<h3>Interpublic Gr of Cos's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Interpublic Gr of Cos's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>1.25%</strong> as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.</p>
<p><strong>Net Margin:</strong> Interpublic Gr of Cos's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>15.32%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Interpublic Gr of Cos's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>12.15%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Interpublic Gr of Cos's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.55%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Interpublic Gr of Cos's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.18</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


What Analysts Are Saying About Interpublic Gr of Cos Stock

<p>During the last three months, 10 analysts shared their evaluations of Synchrony Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $42.8, a high estimate of $50.00, and a low estimate of $30.00. This current average reflects an increase of 7.0% from the previous average price target of $40.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714064488_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The perception of Synchrony Finl by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mihir Bhatia</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>James Fotheringham</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$41.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Donald Fandetti</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mark Devries</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Bill Carcache</td>
<td>Wolfe Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$50.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$47.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>David Scharf</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Outperform</td>
<td>$49.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Mihir Bhatia</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Jeffrey Adelson</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$30.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Synchrony Finl. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Synchrony Finl compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Synchrony Finl's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Synchrony Finl's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SYF/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Synchrony Finl analyst ratings.</strong></a></p>
<h2>Discovering Synchrony Finl: A Closer Look</h2>
<p>Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).</p>
<h3>Synchrony Finl: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Synchrony Finl displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately <strong>18.3%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>11.72%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Synchrony Finl's ROE excels beyond industry benchmarks, reaching <strong>3.27%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Synchrony Finl's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.37%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Synchrony Finl's debt-to-equity ratio is below the industry average. With a ratio of <b>1.21</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Synchrony Finl Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)

<p>In the latest quarter, 22 analysts provided ratings for Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">16</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">12</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $79.0, a high estimate of $88.00, and a low estimate of $65.00. Observing a 6.51% increase, the current average has risen from the previous average price target of $74.17. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714064480_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>A clear picture of Academy Sports's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Will Gaertner</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Jonathan Matuszewski</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$85.00</td>
<td>-</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$80.00</td>
<td>-</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$72.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Justin Kleber</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Kate Fitzsimons</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$83.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$78.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$80.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$75.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$83.00</td>
<td>-</td>
</tr>
<tr>
<td>Christopher Horvers</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$87.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Beth Reed</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$77.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Outperform</td>
<td>$83.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$83.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Justin Kleber</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Kate Fitzsimons</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$88.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Beth Reed</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$77.00</td>
<td>$73.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Academy Sports. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Academy Sports compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Academy Sports's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Academy Sports's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ASO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Academy Sports analyst ratings.</strong></a></p>
<h2>Delving into Academy Sports's Background</h2>
<p>Academy Sports and Outdoors Inc is engaged in the retail business of sporting goods and outdoor recreation products. The product categories of the company are outdoors, apparel, sports &amp; recreation, and footwear.</p>
<h3>Understanding the Numbers: Academy Sports's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Academy Sports's remarkable performance in 3 months is evident. As of 31 January, 2024, the company achieved an impressive revenue growth rate of <strong>2.77%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Academy Sports's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>9.37%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Academy Sports's ROE excels beyond industry benchmarks, reaching <strong>8.97%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Academy Sports's ROA excels beyond industry benchmarks, reaching <strong>3.5%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Academy Sports's debt-to-equity ratio is below the industry average. With a ratio of <b>0.87</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Analyst Landscape: 22 Takes On Academy Sports

<p>Deutsche Bank  analyst Scott Deuschle   maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and lowers the price target from $240 to $225.</p>


Deutsche Bank Maintains Buy on Boeing, Lowers Price Target to $225

<p>In the preceding three months, 5 analysts have released ratings for Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $228.4, a high estimate of $240.00, and a low estimate of $218.00. This current average reflects an increase of 7.13% from the previous average price target of $213.20. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714064459_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Avery Dennison by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$220.00</td>
<td>$218.00</td>
</tr>
<tr>
<td>Matt Roberts</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$240.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$234.00</td>
<td>$223.00</td>
</tr>
<tr>
<td>Jeffrey Zekaukas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$218.00</td>
<td>$185.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Avery Dennison. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Avery Dennison compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Avery Dennison's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Avery Dennison's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AVY/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Avery Dennison analyst ratings.</strong></a></p>
<h2>Delving into Avery Dennison's Background</h2>
<p>Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.</p>
<h3>Key Indicators: Avery Dennison's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Avery Dennison's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately <strong>4.18%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Avery Dennison's net margin is impressive, surpassing industry averages. With a net margin of <strong>6.78%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Avery Dennison's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>6.83%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Avery Dennison's ROA excels beyond industry benchmarks, reaching <strong>1.75%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Avery Dennison's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.52</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Analyst Landscape: 5 Takes On Avery Dennison

CNBC Halftime Report Final Trades: Verizon Communications, General Motors, SPDR Select Sector Fund - Utilities

The market has been high on Achilles Therapeutics PLC (ACHL)  stock recently. ACHL gets a Bullish score from InvestorsObserver Stock Sentiment Indicator. Achilles Therapeutics PLC has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ACHL!See Full ACHL ReportWhat is Stock Sen

How Will the Market React to Achilles Therapeutics PLC (ACHL) Stock Getting a Bullish Rating

Achilles Therapeutics PLC (ACHL) is higher by Wednesday morning, with the stock adding 1.61% in pre-market trading to 1.26. ACHL's short-term technical score of 52 indicates that the stock has traded more bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 1

Premarket Mover: Achilles Therapeutics PLC (ACHL) Up 1.61%

Achilles Therapeutics PLC (ACHL) is up 3.20% today. ACHL has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on ACHL!See Full ACHL ReportACHL stock closed at $1.25 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as mo

Premarket Mover: Achilles Therapeutics PLC (ACHL) Up 3.20%

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>We&rsquo;re diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!</p>



<p>Moving stocks this morning are strong early morning trading, earnings reports and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>HWH International</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/hwh-stock-quote/"><strong>HWH</strong></a>) stock is rocketing more than 85% with strong early morning trading.</li>



<li><strong>Zhongchao </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/zcmd-stock-quote/"><strong>ZCMD</strong></a>) shares are soaring over 50% with heavy pre-market trading.</li>



<li><strong>Hub Cyber Security</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/"><strong>HUBC</strong></a>) stock is surging more than 30% with increasing trading activity on Thursday morning.</li>



<li><strong>Brooge Energy</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/brog-stock-quote/"><strong>BROG</strong></a>) shares are rising over 21% as it also experiences strong trading today.</li>



<li><strong>A.k.a. Brands</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/aka-stock-quote/"><strong>AKA</strong></a>) stock is increasing 17% without any clear news this morning.</li>



<li><strong>Orgenesis </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/orgs-stock-quote/"><strong>ORGS</strong></a>) shares are gaining more than 16% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318209149&amp;type=PDF&amp;symbol=ORGS&amp;cdn=778bdb482c018a07a4dec09546e61eb2&amp;companyName=Orgenesis+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-02">following recent insider buying</a>.</li>



<li><strong>Candel Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/"><strong>CADL</strong></a>) stock is climbing over 15% despite a lack of news on Thursday.</li>



<li><strong>AngioDynamics </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/ango-stock-quote/"><strong>ANGO</strong></a>) shares are jumping more than 15% after releasing its <a href="https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-year-2024-third-quarter-financial-results-updates-fiscal">fiscal Q3 2024 earnings report</a>.</li>



<li><strong>Addex Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/"><strong>ADXN</strong></a>) stock is getting an over 14% boost as it continues to rally on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318212492&amp;type=PDF&amp;symbol=ADXN&amp;cdn=b99f04f9c986cd5ad74a2038763835fe&amp;companyName=Addex+Therapeutics+Ltd&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-03">neurological company launch</a>.</li>



<li><strong>Destiny Tech100</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/dxyz-stock-quote/"><strong>DXYZ</strong></a>) shares are up more than 13% without any clear news to report.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>Casa Systems</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/casa-stock-quote/"><strong>CASA</strong></a>) stock is plummeting over 31% after <a href="https://www.nasdaq.com/press-release/casa-systems-initiates-court-supervised-chapter-11-sale-process-for-businesses-2024">filing for bankruptcy</a>.</li>



<li><strong>View </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/view-stock-quote/"><strong>VIEW</strong></a>) stock is diving more than 29% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318216587&amp;type=PDF&amp;symbol=VIEW&amp;cdn=229f694a9f04258b182e980a2525d125&amp;companyName=View+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-04">alongside a delisting notice</a>.</li>



<li><strong>Globavend </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/gvh-stock-quote/"><strong>GVH</strong></a>) shares are tumbling over 27% on Thursday morning.</li>



<li><strong>Flora Growth</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/flgc-stock-quote/"><strong>FLGC</strong></a>) stock is taking a more than 20% beating after <a href="https://finance.yahoo.com/news/flora-growth-corp-announces-launch-003700210.html">launching a share offering</a>.</li>



<li><strong>Achilles Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/achl-stock-quote/"><strong>ACHL</strong></a>) shares are sliding over 19% alongside its <a href="https://www.nasdaq.com/press-release/achilles-therapeutics-reports-fourth-quarter-and-year-end-2023-financial-results-and">Q4 2023 earnings report</a>.</li>



<li><strong>XTI Aerospace</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtia-stock-quote/"><strong>XTIA</strong></a>) stock is decreasing more than 14% <a href="https://investorplace.com/2024/04/why-is-xti-aerospace-xtia-stock-up-89-today/">after rallying yesterday</a>.</li>



<li><strong>Reliance Global</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/"><strong>RELI</strong></a>) shares are declining over 13% ahead of its <a href="https://www.nasdaq.com/press-release/reliance-global-group-schedules-fourth-quarter-2023-financial-results-and-business">Q4 conference call</a>.</li>



<li><strong>Jiuzi </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/jzxn-stock-quote/"><strong>JZXN</strong></a>) stock is slipping more than 13% as it continues to fall <a href="https://www.nasdaq.com/press-release/jiuzi-holdings-enters-into-a-non-binding-loi-for-the-acquisition-of-shenzhen">on acquisition plans</a>.</li>



<li><strong>Digital Health Acqsuitiion</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/dhac-stock-quote/"><strong>DHAC</strong></a>) shares are dipping over 13% without any apparent news.</li>



<li><strong>Telesis Bio</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/tbio-stock-quote/"><strong>TBIO</strong></a>) stock closes out our pre-market stock movers down more than 11%.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-4th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

EC, ABAT and BORR among pre-market losers

ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Achilles Therapeutics</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/achl-stock-quote/"><strong>ACHL</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Achilles Therapeutics reported earnings per share of -46 cents. This was below the analyst estimate for EPS of -14 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/04/achl-stock-earnings-achilles-therapeutics-for-q4-of-2023/">ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

Achilles Therapeutics GAAP EPS of -$0.46 misses by $0.32

BRNS, UPC and KWE among mid-day movers

Piper downgrades Achilles to neutral, cites latest data

ABAT

ANGO

BORR

BRNS

BROG

DHAC

HSDT

HUBC

JZXN

LIFW

NOTV

ORGS

REPX

TBIO

ZCMD

Press Releases

Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Opinion

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

Health Care

Achilles Therapeutics Announces Publication of Nature Cancer 'Comment' on Strategy for Improved Neoantigen Immunogenicity Prediction

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights